Gene · 10964
Papers1,779
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,779
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Robust antiviral innate immune response and miRNA regulatory network were identified in ZIKV-infected cells: implications in the pathogenesis of ZIKV infection. | Virus Genes | 2025 | 39955676 | PubTator, text mining | PubMed |
| Regulation of innate immune response by miRNAs up-regulated in Stevens-Johnson syndrome with severe ocular complications. | Sci Rep | 2025 | 39762541 | PubTator, text mining | PubMed |
| Two-transcript signature for differentiation and clinical outcomes in severe fever with thrombocytopenia syndrome (SFTS) patients: a double-blind, multicenter, validation study. | J Clin Microbiol | 2025 | 39688402 | PubTator, text mining | PubMed |
| A multi-omics strategy to understand PASC through the RECOVER cohorts: a paradigm for a systems biology approach to the study of chronic conditions. | Front Syst Biol | 2024 | 40809128 | PubTator, text mining | PubMed |
| Unraveling IFI44L's biofunction in human disease. | Front Oncol | 2024 | 39737399 | PubTator, text mining | PubMed |
| Differential transcriptomic host responses in the early phase of viral and bacterial infections in human lung tissue explants ex vivo. | Respir Res | 2024 | 39395995 | PubTator, text mining | PubMed |
| Type I Interferonopathy among Non-Elderly Female Patients with Post-Acute Sequelae of COVID-19. | Viruses | 2024 | 39339845 | PubTator, text mining | PubMed |
| Genome-wide analysis reveals the MORC3-mediated repression of PD-L1 expression in head and neck cancer. | Front Cell Dev Biol | 2024 | 39329063 | PubTator, text mining | PubMed |
| Evaluation of Laser Intensity Effect on Photodynamic Therapy Efficacy. | J Lasers Med Sci | 2024 | 39193105 | PubTator, text mining | PubMed |
| Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next? | Int Immunopharmacol | 2024 | 39191122 | PubTator, text mining | PubMed |
| Cell-type-specific expression analysis of liver transcriptomics with clinical parameters to decipher the cause of intrahepatic inflammation in chronic hepatitis B. | Imeta | 2024 | 39135698 | PubTator, text mining | PubMed |
| Construction of a panoramic mRNA map of adult noncystic fibrosis bronchiectasis and a preliminary study of the underlying molecular mechanisms. | Eur J Med Res | 2024 | 39127654 | PubTator, text mining | PubMed |
| LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis. | Lupus | 2024 | 39126180 | PubTator, text mining | PubMed |
| Comprehensive microarray analysis of severe preeclampsia placenta to identify differentially expressed genes, biological pathways, hub genes, and their related non-coding RNAs. | Placenta | 2024 | 39121584 | PubTator, text mining | PubMed |
| Human Immunodeficiency Virus-Induced Interferon-Stimulated Gene Expression Is Associated With Monocyte Activation and Predicts Viral Load. | Open Forum Infect Dis | 2024 | 39104769 | PubTator, text mining | PubMed |
| Development and evaluation of a chronic kidney disease risk prediction model using random forest. | Front Genet | 2024 | 38993480 | PubTator, text mining | PubMed |
| ACSL4 upregulates IFI44 and IFI44L expression and promotes the proliferation and invasiveness of head and neck squamous cell carcinoma cells. | Cancer Sci | 2024 | 38989827 | PubTator, text mining | PubMed |
| IFN-I Score and Rare Genetic Variants in Children with Systemic Lupus Erythematosus. | Biomedicines | 2024 | 38927451 | PubTator, text mining | PubMed |
| IFN-signaling gene expression as a diagnostic biomarker for monogenic interferonopathies. | JCI Insight | 2024 | 38885315 | PubTator, text mining | PubMed |
| Discovery of Potential Drug Targeting Key Genes in Alzheimer's Disease: Insights from Transcriptome Analysis and Molecular Docking. | J Mol Neurosci | 2024 | 38802701 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10964/papers?page=7